These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2331582)

  • 21. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin release by nicotine: the site of action.
    Feldberg W; Guertzenstein PG; Rocha e Silva M
    Br J Pharmacol; 1975 Aug; 54(4):463-74. PubMed ID: 1236754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of oxytocin and vasopressin release from rat neurosecretosomes: the roles of VIP oxytocin and GABA.
    Falke N
    Neuropeptides; 1991 Mar; 18(3):143-7. PubMed ID: 2067599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA inhibition of central angiotensin II and hypertonic CSF pressor responses.
    Brennan TJ; Haywood JR
    Brain Res; 1983 May; 267(2):261-9. PubMed ID: 6871675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The central pressor actions of substance P are inhibited by GABA.
    Schneider B; Ganten D; Lang RE; Unger T
    Eur J Pharmacol; 1986 Nov; 131(1):31-7. PubMed ID: 2434340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of central injection of kyotorphin and L-arginine on oxytocin and vasopressin release and blood pressure in conscious rats.
    Summy-Long JY; Bui V; Gestl S; Koehler-Stec E; Liu H; Terrell ML; Kadekaro M
    Brain Res Bull; 1998; 45(4):395-403. PubMed ID: 9527014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baroreceptor influences on oxytocin and vasopressin secretion.
    Morris M; Alexander N
    Hypertension; 1989 Feb; 13(2):110-4. PubMed ID: 2914733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Butyrylcholinesterase fluctuation in male albino rats with intracerebroventricular injection of gamma aminobutyric acid, muscimol, and picrotoxin.
    Rattan AK; Dhatt RK; Mangat HK
    Clin Physiol Biochem; 1990; 8(1):16-22. PubMed ID: 2323158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in succinate dehydrogenase activity of rats after intraventricular injections of GABA, muscimol and picrotoxin.
    Rattan AK; Dhatt RK; Mangat HK
    Indian J Exp Biol; 1990 Sep; 28(9):845-8. PubMed ID: 2279777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.
    Bisset GW; Clark BJ; Krejcí I; Polácek I; Rudinger J
    Br J Pharmacol; 1970 Oct; 40(2):342-60. PubMed ID: 4321760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of an osmotic stimulus on the release of neurohypophysial hormones in the cat: preferential release of vasopressin with a possible involvement of the area postrema.
    Bissett GW; Chowdreyt HS; Feldberg W
    J Neuroendocrinol; 1990 Apr; 2(2):201-7. PubMed ID: 19210384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exogenous relaxin on oxytocin and vasopressin release and the intramammary pressure response to central hyperosmotic challenge.
    Wilson BC; Summerlee AJ
    J Endocrinol; 1994 Apr; 141(1):75-80. PubMed ID: 8014606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABAergic inhibition of hypertonic saline-induced vasopressin-dependent hypertension.
    Brennan TJ; Haywood JR
    J Pharmacol Exp Ther; 1985 Jun; 233(3):663-71. PubMed ID: 4009486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gamma-aminobutyric acid and muscimol on corticosterone secretion in rats.
    Borycz J; Borycz JA; Bugajski J
    J Physiol Pharmacol; 1992 Sep; 43(3):259-69. PubMed ID: 1493256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GABA receptor stimulation increases the release of vasopressin and oxytocin in vitro.
    Fjalland B; Christensen JD; Grell S
    Eur J Pharmacol; 1987 Oct; 142(1):155-8. PubMed ID: 2826174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of vasopressin on oxytocin-induced changes in urine flow in the male rat.
    Forsling ML; Brimble MJ; Balment RJ
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):216-20. PubMed ID: 7113593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of N-methyl-D-aspartic acid receptor activation in oxytocin and vasopressin release after osmotic stimuli in rats.
    Onaka T; Yagi K
    J Neuroendocrinol; 2001 Feb; 13(2):166-74. PubMed ID: 11168842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscimol inhibits ADH release induced by hypertonic sodium chloride in rats.
    Iovino M; De Caro G; Massi M; Steardo L; Poenaru S
    Pharmacol Biochem Behav; 1983 Aug; 19(2):335-8. PubMed ID: 6634883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurosteroid regulation of oxytocin and vasopressin release from the rat supraoptic nucleus.
    Widmer H; Ludwig M; Bancel F; Leng G; Dayanithi G
    J Physiol; 2003 Apr; 548(Pt 1):233-44. PubMed ID: 12588901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.